High Court Agrees To Hear Teva MS Drug Patent Suit
The U.S. Supreme Court on Monday agreed to hear Teva Pharmaceuticals USA Inc.'s appeal of a Federal Circuit decision invalidating several patents covering its lucrative multiple sclerosis drug Copaxone, in a...To view the full article, register now.
Already a subscriber? Click here to view full article